Alkem Laboratories Limited

NSE: ALKEM · Healthcare · Pharmaceuticals · Market cap ₹63,417 Cr

₹5,304.00+7.00 (+0.13%)

· Prev close ₹5,297.00 · 52W ₹4,811–5,934

Day range for 8 Nov not in the price history yet · 6 Nov ₹5,141.00–5,297.00

Last 4 quarters: profit −6.7% on the 4 beforeShare price +0.1% in a month12 Nov Sep-quarter results

Growth

Loading selected research…

NSE: ALKEM · Healthcare · Pharmaceuticals · Market cap ₹63,417 Cr

₹5,304.00+7.00 (+0.13%)

· Prev close ₹5,297.00 · 52W ₹4,811–5,934

Day range for 8 Nov not in the price history yet · 6 Nov ₹5,141.00–5,297.00

Last 4 quarters: profit −6.7% on the 4 beforeShare price +0.1% in a month12 Nov Sep-quarter results

+9%−1%−23%−22%

Sep 25Dec 25Mar 26Jun 26

FY22–26 CAGR 8.2%

A quarter on its year-earlier quarter and a multi-year CAGR are different measures; the dashed line is context, not a like-for-like test.

3,4153,3743,1443,3714,0013,7373,6033,740

Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26

702641306664765636236520

Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26

3,1133,6744,9055,6886,4017,3578,3448,86510,63411,59912,66812,96514,712

FY14FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

—32.862.074.652.863.694.3132.6137.682.3150.2181.1192.5

FY14FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Not comparable: EPS for FY14 is on a different share count from FY26.

Loading selected research…